• Cognizant Technology Solutions recently reported second-quarter 2026 results showing higher sales of US$5,481 million year over year, modestly lower net income of US$636 million, reaffirmed and raised elements of its 2026 revenue outlook, and declared a quarterly cash dividend of US$0.33 per share payable on August 25, 2026.
• Alongside new multi-year client wins, expanded AI partnerships, and the launch of a dedicated EMEA AI Unit, the company is tightening its focus on enterprise AI solutions that aim to move clients from experimentation to production-scale deployments.
• We’ll now examine how Cognizant’s updated 2026 guidance and expanded enterprise AI initiatives influence its existing investment narrative and risk-reward profile.

AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Cognizant Technology Solutions Investment Narrative Recap

To stay invested in Cognizant, you need to believe it can convert its enterprise AI push into steady, profitable services work rather than commoditized, lower-margin projects. The latest Q2 results and 2026 outlook point to stable, incremental revenue growth, but only modest earnings progression, so they do not materially change the near term balance between the key catalyst of AI-driven deal ramp-ups and the ongoing risk of pricing pressure and wage and attrition-related margin strain.

Among the recent updates, the launch of the EMEA AI Unit looks most relevant to this earnings release and guidance. It ties directly into Cognizant’s effort to move clients from AI pilots to scaled production, which is central to its growth thesis. If these offerings translate into larger, multi-year deals similar to recent wins in insurance and Thailand, they could bolster the company’s ability to offset competitive and cost pressures.

Yet, despite this progress, investors should be aware that rising client expectations for AI driven productivity could still compress pricing and profitability...

Cognizant Technology Solutions' narrative projects $24.9 billion revenue and $3.1 billion earnings by 2029. This requires 5.2% yearly revenue growth and a $0.9 billion earnings increase from $2.2 billion today.

Uncover how Cognizant Technology Solutions' forecasts yield a $63.90 fair value, a 15% upside to its current price.

Exploring Other Perspectives

Before this news, the most cautious analysts were assuming only about 4.4% annual revenue growth and US$3.2 billion of earnings by 2029, so if you are worried that fixed bid and transaction based contracts could actually weigh on margins, this more pessimistic view highlights how sharply expectations can differ and why it is worth comparing several scenarios against the company’s new AI focused momentum.

Explore 9 other fair value estimates on Cognizant Technology Solutions - why the stock might be worth over 2x more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Cognizant Technology Solutions research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free Cognizant Technology Solutions research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Cognizant Technology Solutions' overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 21 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.